GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
NovaBay Pharmaceuticals Inc. (NBY) [hlAlert]

NovaBay Pharmaceuticals, Inc. (NovaBay) is a clinical-stage biopharmaceutical company developing synthetic anti-infective product candidates to treat and prevent a range of infections, without developing resistance, in hospital and non-hospital environments. The Company?s Aganocide compounds
are synthetic forms of N-chlorinated antimicrobial molecules, which are effective and acting anti-infective molecules produced by white blood cells when defending the body against invading pathogens. In preclinical testing, its Aganocide compounds have demonstrated the ability to destroy bacteria, against which they have been tested. On March 25, 2009, the Company announced that it had entered into an agreement with Galderma S.A. to develop and commercialize its Aganocide compounds.
.
( Total: 3 Current Stock Recommendations )
NovaBay Pharmaceuticals Inc.   (3)
Buy 100%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Buy NBY
down 38.09 %

Rating:
Buy NBY
down 38.09 %

Rating:
Buy NBY
down 90.15 %

Your Recent Stocks
SymbolLastChange
NBY 0.39 down  -2.50 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy